Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'COMBINATION CHEMOTHERAPY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 2368 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Argiris, A; Murren, JR
      Advances in chemotherapy for small cell lung cancer: Single-agent activityof newer agents

      CANCER JOURNAL
    2. Kyle, RA
      Management of patients with multiple myeloma: Emphasizing the role of high-dose therapy

      CLINICAL LYMPHOMA
    3. Visco, C; Medeiros, LJ; Mesina, OM; Rodriguez, MA; Hagemeister, FB; McLaughlin, P; Romaguera, JE; Cabanillas, F; Sarris, AH
      Non-Hodgkin's lymphoma affecting the testis: Is it curable with doxorubicin-based therapy?

      CLINICAL LYMPHOMA
    4. Liu, XS; Shi, Y; Han, EKH; Chen, ZH; Rosenberg, SH; Giranda, VL; Luo, Y; Ng, SC
      Downregulation of Akt1 inhibits anchorage-independent cell growth and induces apoptosis in cancer cells

      NEOPLASIA
    5. Steer, C; Harper, P
      Is there any place for cytotoxic chemotherapy in endometrial cancer?

      BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY
    6. Dowling, AJ; Prince, HM; Wirth, A; Wolf, M; Januszewicz, EH; Juneja, S; Seymour, JF; Gates, P; Smith, JG
      High-dose therapy and autologous transplantation for lymphoma: The Peter MacCallum Cancer Institute experience

      INTERNAL MEDICINE JOURNAL
    7. Frenkel, GD; Caffrey, PB
      A prevention strategy for circumventing drug resistance in cancer chemotherapy

      CURRENT PHARMACEUTICAL DESIGN
    8. Karapetis, CS; Yip, D; Virik, K; Strickland, A; Ryder, K; Cowling, M; Harper, PG
      Epirubicin, cisplatin, and prolonged or brief infusional 5-fluorouracil inthe treatment of carcinoma of unknown primary site

      MEDICAL ONCOLOGY
    9. Meirow, D; Nugent, D
      The effects of radiotherapy and chemotherapy on female reproduction

      HUMAN REPRODUCTION UPDATE
    10. Howell, SJ; Shalet, SM
      Testicular function following chemotherapy

      HUMAN REPRODUCTION UPDATE
    11. Tester, W; Mora, J
      Innovative treatments for advanced non-small cell lung cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS

    12. Water-soluble trioxanes as potent and safe antimalarial agents

      EXPERT OPINION ON THERAPEUTIC PATENTS
    13. Zisman, DA; McCune, WJ; Tino, G; Lynch, JP
      Drug-induced pneumonitis: The role of methotrexate

      SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES
    14. Tognoni, A; Pensa, F; Vaira, F; Vigani, A; Bancalari, L; Fiasella, L; Maggiani, R; Canessa, P; Pronzato, P
      A three-drug regimen (gemcitabine, ifosfamide and cisplatin) for advanced non-small-cell lung cancer

      JOURNAL OF CHEMOTHERAPY
    15. Schimmer, AD; Ali, V; Stewart, K; Imrie, K; Keating, A
      Male sexual function after autologous blood or marrow transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    16. Stuart, MJ; Chao, NS; Horning, SJ; Wong, RM; Negrin, RS; Johnston, LJ; Shizuru, JA; Long, GD; Blume, KG; Stockerl-Goldstein, KE; Goldstein, S
      Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    17. Hayes, DF; Yamauchi, H; Broadwater, G; Cirrincione, CT; Rodrigue, SP; Berry, DA; Younger, J; Panasci, LL; Millard, F; Duggan, DB; Norton, L; Henderson, IC
      Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and leukemia group B study 8662

      CLINICAL CANCER RESEARCH
    18. Veal, GJ; Dias, C; Price, L; Parry, A; Errington, J; Hale, J; Pearson, ADJ; Boddy, AV; Newell, DR; Tilby, MJ
      Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy

      CLINICAL CANCER RESEARCH
    19. Williams, JI; Weitman, S; Gonzalez, CM; Jundt, CH; Marty, J; Stringer, SD; Holroyd, KJ; McLane, MP; Chen, QM; Zasloff, M; Von Hof, DD
      Squalamine treatment of human tumors in nu/nu mice enhances platinum-basedchemotherapies

      CLINICAL CANCER RESEARCH
    20. Pashankar, FD; Steinbok, P; Blair, G; Pritchard, S
      Successful chemotherapeutic decompression of primary endodermal sinus tumor presenting with severe spinal cord compression

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    21. Hamilton, VM; Norris, C; Bunin, N; Goldwein, JW; Bunin, GR; Lange, B; Meadows, AT
      Cyclophosphamide-based, seven-drug hybrid and low-dose involved field radiation for the treatment of childhood and adolescent Hodgkin disease

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    22. Chorost, MI; McKinley, B; Tschoi, M; Ghosh, BC
      The management of the unknown primary

      JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
    23. Rice, LW
      What's new in obstetrics and gynecology

      JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
    24. Vang, R; Medeiros, LJ; Fuller, GN; Sarris, AH; Deavers, M
      Non-Hodgkin's lymphoma involving the gynecologic tract: A review of 88 cases

      ADVANCES IN ANATOMIC PATHOLOGY
    25. Henshaw, RM; Priebat, DA; Perry, DJ; Shmookler, BM; Malawer, MM
      Survival after induction chemotherapy and surgical resection for high-grade soft tissue sarcoma. Is radiation necessary?

      ANNALS OF SURGICAL ONCOLOGY
    26. Otton, G; Higgins, S; Phillips, KA; Quinn, M
      A case of early-stage epithelial ovarian cancer in pregnancy

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    27. Bafna, UD; Umadevi, K; Kumaran, C; Nagarathna, DS; Shashikala, P; Tanseem, R
      Germ cell tumors of the ovary: Is there a role for aggressive cytoreductive surgery for nondysgerminomatous tumors?

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    28. Hansen, SW
      Gemcitabine in the treatment of ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    29. Stein, RS; Greer, JP; Goodman, S; Brandt, SJ; Morgan, D; Macon, WR; McCurley, TL; Wolff, SN
      Intensified preparative regimens and allogeneic transplantation in refractory or relapsed intermediate and high grade non-Hodgkin's lymphoma

      LEUKEMIA & LYMPHOMA
    30. Cartron, G; Voillat, L; Desablens, B; Le Maignan, C; Milpied, N; Foussard, C; Dugay, J; Maakaroun, A; De Muret, A; Colombat, P
      Continuous infusion of vincristine-doxorubicin with bolus of Dexamethasone(VAD) alternated with CHEP in the treatment of patients over 60 years old with aggressive non-Hodgkin's lymphoma

      LEUKEMIA & LYMPHOMA
    31. Enschede, SH; Shahidi, H; Venugopal, P; Riley, MB; Huang, RW; Jajeh, A; Preisler, HD; Gregory, SA
      Effectiveness of interferon-alfa and mid-cycle chemotherapy added to an anthracycline-based regimen in the treatment of aggressive non-Hodgkin's lymphoma

      LEUKEMIA & LYMPHOMA
    32. Kruczynski, A; Hill, BT
      Vinflunine, the latest Vinca alkaloid in clinical development - A review of its preclinical anticancer properties

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    33. Calderoni, A; Cerny, T
      Taxanes in lung cancer: a review with focus on the European experience

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    34. Grossi, F; Scolaro, T; Tixi, L; Loprevite, M; Ardizzoni, A
      The role of systemic chemotherapy in the treatment of brain metastases from small-cell lung cancer

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    35. Dittmann, H; Sokler, M; Kollmannsberger, C; Dohmen, BM; Baumann, C; Kopp, A; Bares, R; Claussen, CD; Kanz, L; Bokemeyer, C
      Comparison of (18)FDG-PET with CT scans in the evaluation of patients withresidual and recurrent Hodgkin's lymphoma

      ONCOLOGY REPORTS
    36. Dawson, LK; Nussey, F; Oliver, TB; Marks, RC; Leonard, RCF
      Osteonecrosis of the femoral head following adjuvant chemotherapy for breast cancer

      BREAST
    37. Batist, G
      Improving the therapeutic index when using Myocet (TM) in the treatment ofmetastatic breast cancer

      BREAST
    38. Sileni, VC; Nortilli, R; Aversa, SML; Paccagnella, A; Medici, M; Corti, L; Favaretto, AG; Cetto, GL; Monfardini, S
      Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients

      MELANOMA RESEARCH
    39. Kosmas, C; Tsavaris, N; Panopoulos, C; Vadiaka, M; Stavroyianni, N; Kourelis, T; Malamos, N; Antonopoulos, M; Kalofonos, HP
      Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane plus platinum-based regimens

      EUROPEAN JOURNAL OF CANCER
    40. Smorenburg, CH; Sparreboom, A; Bontenbal, M; Verweij, J
      Combination chemotherapy of the taxanes and antimetabolites: its use and limitations

      EUROPEAN JOURNAL OF CANCER
    41. Kudawara, I; Ueda, T; Yoshikawa, H; Miyama, T; Yamamoto, T; Nishizawa, Y
      In vivo inhibition of tumour growth by dexamethasone in murine osteosarcomas

      EUROPEAN JOURNAL OF CANCER
    42. Rougier, P
      Palliative and adjuvant chemotherapy in colorectal cancer

      EUROPEAN JOURNAL OF CANCER
    43. Dearnaley, DP; Huddart, RA; Horwich, A
      Regular review - Managing testicular cancer

      BRITISH MEDICAL JOURNAL
    44. Waltmire, CN; Alberts, DS; Dorr, RT
      Sequence-dependent cytotoxicity of combination chemotherapy using paclitaxel, carboplatin and bleomycin in human lung and ovarian cancer

      ANTI-CANCER DRUGS
    45. Niitsu, N; Iijima, K
      Full-dose CHOP chemotherapy combined with granulocyte colony-stimulating factor for aggressive non-Hodgkin's lymphoma in elderly patients: a prospective study

      ANNALS OF HEMATOLOGY
    46. Willich, NA; Reinartz, G; Reers, B; Hiddemann, W; Tiemann, M; Parwaresch, R; Grothaus-Pinke, B; Kocik, J; Koch, P
      Radiotherapy in early stage gastrointestinal lymphoma: Results of the German GIT-NHL group

      ANNALS OF HEMATOLOGY
    47. Hartley, A; Spooner, D; Brunt, AM
      Management of malignant phaeochromocytoma: A retrospective review of the use of MIBG and chemotherapy in the West Midlands

      CLINICAL ONCOLOGY
    48. Chalmers, AJ; Gillham, CM; Plowman, PN
      Nuchal aggressive fibromatosis in childhood: Two instructive case reports

      CLINICAL ONCOLOGY
    49. Erdlenbruch, B; Pekrun, A; Roth, C; Grunewald, RW; Kern, W; Lakomek, M
      Cisplatin nephrotoxicity in children after continuous 72-h and 3x1-h infusions

      PEDIATRIC NEPHROLOGY
    50. Rueffer, U; Breuer, K; Josting, A; Lathan, B; Sieber, M; Manzke, O; Grotenhermen, FJ; Tesch, H; Bredenfeld, H; Koch, P; Nisters-Backes, H; Wolf, J; Engert, A; Diehl, V
      Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment

      ANNALS OF ONCOLOGY
    51. du Bois, A; Luck, HJ; Pfisterer, J; Schroeder, W; Blohmer, JU; Kimmig, R; Moebus, V; Quaas, J
      Second-line carboplatin and gemcitabine in platinum sensitive ovarian cancer - a dose-finding study by the Arbeitsgemeinschaft Gynakologische Onkologie (AGO) Ovarian Cancer Study Group

      ANNALS OF ONCOLOGY
    52. Vermorken, JB; Zanetta, G; Oliveira, CFD; van der Burg, MEL; Lacave, AJ; Teodorovic, I; Boes, GH; Colombo, N
      Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma ofthe uterine cervix: An EORTC Gynecological Cancer Cooperative Group study

      ANNALS OF ONCOLOGY
    53. Khuri, FR; Herbst, RS; Fossella, FV
      Emerging therapies in non-small-cell lung cancer

      ANNALS OF ONCOLOGY
    54. Gazet, JC; Ford, HT; Gray, R; McConkey, C; Sutcliffe, R; Quilliam, J; Makinde, V; Lowndes, S; Coombes, RC
      Estrogen-receptor-directed neoadjuvant therapy for breast cancer: Results of a randomised trial using formestane and methotrexate, mitozantrone and mitomycin C (MMM) chemotherapy

      ANNALS OF ONCOLOGY
    55. Saghatchian, M; Fizazi, K; Borel, C; Ducreux, M; Ruffie, P; Le Chevalier, T; Theodore, C
      Carcinoma of an unknown primary site: A chemotherapy strategy based on histological differentiation - results of a prospective study

      ANNALS OF ONCOLOGY
    56. Pierga, JY; Robain, M; Jouve, M; Asselain, B; Dieras, V; Beuzeboc, P; Palangie, T; Dorval, T; Extra, JM; Scholl, S; Pouillart, P
      Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patients

      ANNALS OF ONCOLOGY
    57. Bangalore, N; Bhargava, P; Hawkins, MJ; Bhargava, P
      Sustained response of sarcomatoid renal-cell carcinoma to MAID chemotherapy: Case report and review of the literature

      ANNALS OF ONCOLOGY
    58. Ridwelski, K; Gebauer, T; Fahlke, J; Kroning, H; Kettner, E; Meyer, F; Eichelmann, K; Lippert, H
      Combination chemotherapy with docetaxel and cisplatin for locally advancedand metastatic gastric cancer

      ANNALS OF ONCOLOGY
    59. Ryberg, M; Nielsen, D; Osterlind, K; Skovsgaard, T; Dombernowsky, P
      Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy

      ANNALS OF ONCOLOGY
    60. Matsui, K; Masuda, N; Yana, T; Takada, Y; Kobayashi, M; Nitta, T; Hirashima, T; Fukuoka, M
      Carboplatin calculated with Chatelut's formula plus etoposide for elderly patients with small-cell lung cancer

      INTERNAL MEDICINE
    61. Matsumoto, M; Takeda, Y; Maki, H; Hojo, K; Wada, T; Nishitani, Y; Maekawa, R; Yoshioka, T
      Preclinical in vivo antitumor efficacy of nedaplatin with gemcitabine against human lung cancer

      JAPANESE JOURNAL OF CANCER RESEARCH
    62. Hagemeister, FB; Donato, M
      Ifosfamide-based chemotherapy regimens in treatment of lymphoma: the M.D. Anderson experience

      EUROPEAN JOURNAL OF HAEMATOLOGY
    63. Aurlien, E; Holte, H; Kvaloy, S; Jakobsen, E; Rusten, LS; Kvalheim, G
      Combination chemotherapy containing mitoguazone, ifosfamide, methotrexate,etoposide (MIME) and G-CSF efficiently mobilize peripheral blood progenitor cells in heavily pre-treated relapsed lymphoma patients

      EUROPEAN JOURNAL OF HAEMATOLOGY
    64. Mayer, J; Vasova, I; Koristek, Z; Navratil, M; Klabusay, M; Doubek, M; Vorlicek, J; Cernilova, I; Vodvarka, P; Petrakova, K
      Ifosfamide- and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma

      EUROPEAN JOURNAL OF HAEMATOLOGY
    65. Reiser, M; Bredenfeld, H; Engert, A; Diehl, V
      The role of ifosfamide in the treatment of relapsed and refractory lymphoma

      EUROPEAN JOURNAL OF HAEMATOLOGY
    66. Moore, AS; Cotter, SM; Rand, WM; Wood, CA; Williams, LE; London, CA; Frimberger, AE; L'Heureux, DA
      Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma

      JOURNAL OF VETERINARY INTERNAL MEDICINE
    67. Kimmick, GG; Muss, HB
      Systemic therapy for older women with breast cancer

      ONCOLOGY-NEW YORK
    68. Seidman, AD
      Gemcitabine as single-agent therapy in the management of advanced breast cancer

      ONCOLOGY-NEW YORK
    69. Picozzi, VJ; Pohlman, BL; Morrison, VA; Lawless, GD; Lee, MW; Kerr, RO; Ford, JM; Delgado, DJ; Fridman, M; Carter, WB
      Patterns of chemotherapy administration in patients with intermediate-grade non-Hodgkin's lymphoma

      ONCOLOGY-NEW YORK
    70. Todeschini, G
      High-dose anthracycline induction in adult acute lymphocytic leukemia

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    71. Sharon, N; Neumann, Y; Kenet, G; Schachter, J; Rechavi, G; Toren, A
      Successful pregnancy after high-dose cyclophosphamide and ifosfamide treatment in two postpubertal women

      PEDIATRIC HEMATOLOGY AND ONCOLOGY
    72. Tefferi, A; Li, CY; Reeder, CB; Geyer, SM; Allmer, C; Levitt, R; Michalak, JC; Addo, F; Krook, JE; Witzig, TE; Schaefer, PL; Mailliard, JA
      A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia

      LEUKEMIA
    73. Ribeiro, RC; Fletcher, BD; Kennedy, W; Harrison, PL; Neel, MD; Kaste, SC; Sandlund, JT; Rubnitz, JE; Razzouk, BI; Relling, MV; Pui, CH
      Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma

      LEUKEMIA
    74. Lester, EP; Petroni, GR; Barcos, M; Johnson, JL; Millard, FE; Cooper, MR; Omura, GA; Frei, E; Peterson, BA
      Cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) for advanced-stage Hodgkin's disease: CALGB 8856

      CANCER INVESTIGATION
    75. Hainsworth, JD; Burris, HA; Calvert, SW; Willcutt, NT; Scullin, DC; Bramham, J; Greco, FA
      Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: A phase II trial of the Minnie Pearl Cancer Research Network

      CANCER INVESTIGATION
    76. Jassem, J; Pienkowski, T; Pluzanska, A; Jelic, S; Gorbunova, V; Mrsic-Krmpotic, Z; Berzins, J; Nagykalnai, T; Wigler, N; Renard, J; Munier, S; Weil, C
      Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: Final results of a randomized phase III multicenter trial

      JOURNAL OF CLINICAL ONCOLOGY
    77. Breathnach, OS; Freidlin, B; Conley, B; Green, MR; Johnson, DH; Gandara, DR; O'Connell, M; Shepherd, FA; Johnson, BE
      Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: Sobering results

      JOURNAL OF CLINICAL ONCOLOGY
    78. Gobbi, PG; Ghirardelli, ML; Solcia, M; Di Giulio, G; Merli, F; Tavecchia, L; Berte, R; Davini, O; Levis, A; Broglia, C; Maffe, GC; Ilariucci, F; Dore, R; Ascari, E
      Image-aided estimate of tumor burden in Hodgkin's disease: Evidence of itsprimary prognostic importance

      JOURNAL OF CLINICAL ONCOLOGY
    79. Sureda, A; Arranz, R; Iriondo, A; Carreras, E; Lahuerta, JJ; Garcia-Conde, J; Jarque, I; Caballero, MD; Ferra, C; Lopez, A; Garcia-Larana, J; Cabrera, R; Carrera, D; Ruiz-Romero, MD; Leon, A; Rifon, J; Diaz-Mediavilla, J; Mataix, R; Morey, M; Moraleda, JM; Altes, A; Lopez-Guillermo, A; de la Serna, J; Fernandez-Ranada, JM; Sierra, J; Conde, E
      Autologous stem-cell transplantation for Hodgkin's disease: Results and prognostic factors in 494 patients from the Grupo Espanol de Linfomas/Transplante Autolog de Medula Osea Spanish Cooperative Group

      JOURNAL OF CLINICAL ONCOLOGY
    80. Zanetta, G; Bonazzi, C; Cantu, MG; Bini, S; Locatelli, A; Bratina, G; Mangioni, C
      Survival and reproductive function after treatment of malignant germ cell ovarian tumors

      JOURNAL OF CLINICAL ONCOLOGY
    81. Horvath, L; Bayfield, M; Clifford, A; Painter, D; Clarke, S
      Unusual presentations of germ cell tumors - Case 1. Recurrent laryngeal nerve palsy in mediastinal seminoma

      JOURNAL OF CLINICAL ONCOLOGY
    82. Sarris, AH; Braunschweig, I; Medeiros, LJ; Duvic, M; Ha, CS; Rodriguez, MA; Hagemeister, FB; McLaughlin, P; Romaguera, J; Cox, J; Cabanillas, F
      Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: Preferential cutaneous relapses but high cure rate with doxorubicin-based therapy

      JOURNAL OF CLINICAL ONCOLOGY
    83. Vose, JM; Zhang, MJ; Rowlings, PA; Lazarus, HM; Bolwell, BJ; Freytes, CO; Pavlovsky, S; Keating, A; Yanes, B; van Besien, K; Armitage, JO; Horowitz, MM
      Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: A report from the Autologous Blood and Marrow Transplant Registry

      JOURNAL OF CLINICAL ONCOLOGY
    84. Thomas, D; Brada, M; Stenning, S
      Randomized trial of porcarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: A medical research council trial

      JOURNAL OF CLINICAL ONCOLOGY
    85. Koch, P; del Valle, F; Berdel, WE; Willich, NA; Reers, B; Hiddemann, W; Grothaus-Pinke, B; Reinartz, G; Brockmann, J; Temmesfeld, A; Schmitz, R; Rube, C; Probst, A; Jaenke, G; Bodenstein, H; Junker, A; Pott, C; Schultze, J; Heinecke, A; Parwaresch, R; Tiemann, M
      Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92

      JOURNAL OF CLINICAL ONCOLOGY
    86. Koch, P; del Valle, F; Berdel, WE; Willich, NA; Reers, B; Hiddemann, W; Grothaus-Pinke, B; Reinartz, G; Brockmann, J; Temmesfeld, A; Schmitz, R; Rube, C; Probst, A; Jaenke, G; Bodenstein, H; Junker, A; Pott, C; Schultze, J; Heinecke, A; Parwaresch, R; Tiemann, M
      Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical andconservative or conservative management only in localized gastric lymphoma- Results of the Prospective German Multicenter Study GIT NHL 01/92

      JOURNAL OF CLINICAL ONCOLOGY
    87. Flaherty, LE; Atkins, M; Sosman, J; Weiss, G; Clark, JI; Margolin, K; Dutcher, J; Gordon, MS; Lotze, M; Mier, J; Sorokin, P; Fisher, RI; Appel, C; Du, W
      Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: Results of two phase II cytokineworking group trials

      JOURNAL OF CLINICAL ONCOLOGY
    88. Crist, WM; Anderson, JR; Meza, JL; Fryer, C; Raney, RB; Ruymann, FB; Breneman, J; Qualman, SJ; Wiener, E; Wharam, M; Lobe, T; Webber, B; Maurer, HM; Donaldson, SS
      Intergroup rhabdomyosarcoma study-IV: Results for patients with nonmetastatic disease

      JOURNAL OF CLINICAL ONCOLOGY
    89. Kushner, BH; Wolden, S; LaQuaglia, MP; Kramer, K; Verbel, D; Heller, G; Cheung, NKV
      Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery

      JOURNAL OF CLINICAL ONCOLOGY
    90. Waterhouse, DN; Dos Santos, N; Mayer, LD; Bally, MB
      Drug-drug interactions arising from the use of liposomal vincristine in combination with other anticancer drugs

      PHARMACEUTICAL RESEARCH
    91. Nichols, CR
      Chemotherapy of disseminated germ cell tumors

      WORLD JOURNAL OF UROLOGY
    92. Cohen, EEW; Stadler, WM
      Treatment of metastatic urothelial cancer in the post-MVAC era

      WORLD JOURNAL OF UROLOGY
    93. Michiwa, Y; Earashi, M; Kobayashi, H; Matsuki, N
      Cutaneous metastases from gastric adenocarcinoma treated with combination chemotherapy producing complete response with long survival

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    94. Gadducci, A; Romanini, A
      Adjuvant chemotherapy in early stage uterine sarcomas: An open question

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    95. Trope, C; Kristensen, G; Kisic, J; Kaern, J
      Long-term results from a phase II study of paclitaxel combined with doxorubicin in recurrent platinum refractory ovarian cancer

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    96. Zylberberg, B; Dormont, D; Janklewicz, S; Bretel, JJ; Poncelet, C; Guillet, JL; Madelenat, P
      Response to neo-adjuvant intraperitoneal and intravenous immunochemotherapy followed by interval secondary cytoreduction in stage IIIc ovarian cancer

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    97. Guglielmi, C; Martelli, M; Federico, M; Zinzani, PL; Vitolo, U; Bellesi, G; Santini, G; Tarella, C; Zallio, F; Pregno, P; Di Renzo, N; Resegotti, L
      Risk assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas

      HAEMATOLOGICA
    98. Dazzi, C; Cariello, A; Rosti, G; Tienghi, A; Molino, A; Sabbatini, R; Aieta, M; Frassineti, GL; Vertogen, B; Giovanis, P; Marangolo, M
      Neoadjuvant high dose chemotherapy plus peripheral blood progenitor cells in inflammatory breast cancer: a multicenter phase II pilot study

      HAEMATOLOGICA
    99. Vassilakopoulos, TP; Nadali, G; Angelopoulou, MK; Siakantaris, MP; Dimopoulou, MN; Kontopidou, FN; Rassidakis, GZ; Doussis-Anagnostopoulou, IA; Hatzioannou, M; Vaiopoulos, G; Kittas, C; Sarris, AH; Pizzolo, G; Pangalis, GA
      Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma

      HAEMATOLOGICA
    100. Deliliers, GL; Monni, P
      Nail transverse white bands induced by antileukemic chemotherapy

      HAEMATOLOGICA


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 09:26:16